Current News
Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development
Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development 2023-04-04 04:00:00
